(90 days)
The INVISx™ Burr Hole Lock is intended for use in covering burr holes and in refixation of cranial bone flaps following a craniotomy.
The INVISx™ Burr Hole Lock consists of a two piece polymer implant used to cover the burr hole(s) created during cranial surgery. INVISx™ Burr Hole Lock is packaged sterile and is intended for single (one-time) use only.
The provided document is a 510(k) summary for the Medtronic INVISx™ Burr Hole Lock. It describes the device, its intended use, and its substantial equivalence to a predicate device. However, it does not contain any information about acceptance criteria or a study proving the device meets acceptance criteria.
Such information, particularly detailed performance data, sample sizes, expert qualifications, and ground truth methodologies, is typically found in the more comprehensive 510(k) submission itself, not in the publicly available summary. The summary focuses on demonstrating equivalence to an already approved predicate device based on materials, design, performance specifications, and intended use.
Therefore, I cannot populate the requested table and answer the specific questions based solely on the provided text. The document refers to "performance specifications" in the context of technological comparison, but it does not elaborate on what those specifications are or how they were met through a study.
{0}------------------------------------------------
page 1 of 1
SAFETY AND EFFECTIVENESS SUMMARY X. Medtronic Neurosurgery INVISx™ Burr Hole Lock
Kol3000
This summary of safety and effectiveness is submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.87.
Establishment Registration Number: 2021898
DEC 0 5 2001
Medtronic Neurosurgery Address of Manufacturer: 125 Cremona Drive Goleta CA, 93117 (805) 968-1546 ext. 1773 Fax: (805) 968-5038
Contact Person: Janet McAuley
Date: August 28, 2001
Trade or Proprietary Name: Medtronic INVISx™ Burr Hole Lock
Common, Usual or Classification Name: Burr Hole Cover (21 CFR 882.5250)
Predicate Device Identification:
Medtronic INVISx™ Cranial Fixation System (K010361).
Device Description:
The INVISx™ Burr Hole Lock consists of a two piece polymer implant used to cover the burr hole(s) created during cranial surgery.
INVISx™ Burr Hole Lock is packaged sterile and is intended for single (one-time) use only.
Intended Use:
The INVISx™ Burr Hole Lock is intended for use in covering burr holes and in refixation of cranial bone flaps following a craniotomy.
Intended Use of Predicate Device:
The INVISx™ Cranial Fixation System is intended for use in refixation of cranial bone flaps after a craniotomy.
Technological Comparison:
The INVISx™ Burr Hole Lock is equivalent to the Medtronic INVISx™ Cranial Fixation System (K010361). Substantial equivalence is based upon materials, design, performance specifications and intended use.
{1}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/1/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with its wings spread.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
DEC 0 5 2001
Janet McAuley Regulatory Specialist Medtronic Neurosurgery 125 Cremona Drive Goleta, California 93117
Re: K013000
Trade/Device Name: Medtronic INVISx™ Burr Hole Lock Regulation Number: 21 CFR 888.5250 and 21CFR 888.5330 Regulation Name: Burr hole Cover and Preformed nonalterable cranioplasty plate Regulatory Class: Class II Product Code: GXR and GXN Dated: August 28, 2001 Received: September 6, 2001
Dear Ms. McAuley:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{2}------------------------------------------------
Page 2 - Ms. Janet McAuley
This letter will allow you to begin marketing your device as described in your Section 510(k) I mis letter will anow you to begin mailing of substantial equivalence of your device to a legally premarket notification. The a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and 11 you desire specific ad 1809.10 for in vitro diagnostic devices), please contact the Office of additionally 21 OF N F ar 8659. Additionally, for questions on the promotion and advertising of Compliance at (301) 591-1010 of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Other general mionnation sturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
R. Mark N. Mellema
Celia M. Witten, Ph.D., MD Director Division of General, Restorative And Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
Device Name:
INVISx™ Burr Hole Lock
510(k) Number (if known
page 1 of 1
The INVISx™ Burr Hole Lock is intended for use in covering burr holes and in refixation of cranial bone flaps following a craniotomy.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
CONCURRENCE OF CDRH, OFFICE OF DEVICE EVALUATION (ODE)
Over the Counter Use: or Prescription Use: (Per 21 CFR 801.109)
Mark n Millerson
ral, Restorative
510(k) Number K013000
§ 882.5330 Preformed nonalterable cranioplasty plate.
(a)
Identification. A preformed nonalterable cranioplasty plate is a device that is implanted in a patient to repair a skull defect and is constructed of a material, e.g., stainless steel or vitallium, that cannot be altered or reshaped at the time of surgery without changing the chemical behavior of the material.(b)
Classification. Class II (performance standards).